Arch Innotek, LLC

Biotech · Private

Engineered yeast strain for fermentation-based production of lutein, a bioavailable antioxidant compound

Grants
$662K
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
6
1 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: De Novo Production of Aroma Compounds by Nonconventional Recombinant Yeast$225,000
Federal grantDepartment of Agriculture · Development Of A Low-cost Natural Pigment Production In A Gras Yeast$100,000
Federal grantDepartment of Health and Human Services · Phase I · Develop novel lutein biomanufacturing in a nonmodel yeast via engineered metabolons and metabolic analyses$281,729
Federal grantDepartment of Health and Human Services · Phase I · Develop novel lutein biomanufacturing in a nonmodel yeast via engineered metabolons and metabolic analyses$55,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1922Onramp Invest, Inc.—$5.0M
1923Immunocore——
1924MOGLING BIO INC——
1925Arch Innotek, LLC——
1926GENELANCET BIOSCIENCES INC——
1927CODA Biotherapeutics, Inc.——
1928MOLECULAR EXPRESS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 6
  • Compositions And Methods Of Biosynthesizing Carotenoids And Their Derivativesapplication
  • Compositions And Methods Of Biosynthesizing Carotenoids And Their Derivativesapplication
  • Compositions And Methods Of Biosynthesizing Carotenoids And Their Derivativesgranted
  • Compositions And Methods Of Biosynthesizing Xanthophyllsapplication
  • Compositions And Methods Of Biosynthesizing Carotenoids And Their Derivativesapplication
  • Compositions And Methods Of Biosynthesizing Carotenoids And Their Derivativesapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.